<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>08904085093020</udiDi>
    <basicUdiDi>B-08904085093020</basicUdiDi>
    <tradeName>Medisponge</tradeName>
    <deviceName>Medisponge</deviceName>
    <manufacturerName>EUCARE PHARMACEUTICALS PRIVATE LIMITED</manufacturerName>
    <manufacturerSrn>IN-MF-000017539</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>M040503</emdnCode>
    <emdnDescription>GELATINE SPONGE HAEMOSTATIC DRESSINGS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MSES 1003</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-01T05:09:07.002Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904085093013</udiDi>
    <basicUdiDi>B-08904085093013</basicUdiDi>
    <tradeName>Medisponge</tradeName>
    <deviceName>Medisponge</deviceName>
    <manufacturerName>EUCARE PHARMACEUTICALS PRIVATE LIMITED</manufacturerName>
    <manufacturerSrn>IN-MF-000017539</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>M040503</emdnCode>
    <emdnDescription>GELATINE SPONGE HAEMOSTATIC DRESSINGS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MSES 1002</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-01T05:09:05.793Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904085093006</udiDi>
    <basicUdiDi>B-08904085093006</basicUdiDi>
    <tradeName>Medisponge</tradeName>
    <deviceName>Medisponge</deviceName>
    <manufacturerName>EUCARE PHARMACEUTICALS PRIVATE LIMITED</manufacturerName>
    <manufacturerSrn>IN-MF-000017539</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>M040503</emdnCode>
    <emdnDescription>GELATINE SPONGE HAEMOSTATIC DRESSINGS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MSES 1001</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-01T05:09:04.598Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904085031435</udiDi>
    <basicUdiDi>B-08904085031435</basicUdiDi>
    <tradeName>Scrofalon</tradeName>
    <deviceName>Scrofalon</deviceName>
    <manufacturerName>EUCARE PHARMACEUTICALS PRIVATE LIMITED</manufacturerName>
    <manufacturerSrn>IN-MF-000017539</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>M040503</emdnCode>
    <emdnDescription>GELATINE SPONGE HAEMOSTATIC DRESSINGS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SCFS 1044</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T05:09:03.403Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904085031428</udiDi>
    <basicUdiDi>B-08904085031428</basicUdiDi>
    <tradeName>Scrofalon</tradeName>
    <deviceName>Scrofalon</deviceName>
    <manufacturerName>EUCARE PHARMACEUTICALS PRIVATE LIMITED</manufacturerName>
    <manufacturerSrn>IN-MF-000017539</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>M040503</emdnCode>
    <emdnDescription>GELATINE SPONGE HAEMOSTATIC DRESSINGS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SCFS 1043</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T05:08:56.181Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904085031411</udiDi>
    <basicUdiDi>B-08904085031411</basicUdiDi>
    <tradeName>Scrofalon</tradeName>
    <deviceName>Scrofalon</deviceName>
    <manufacturerName>EUCARE PHARMACEUTICALS PRIVATE LIMITED</manufacturerName>
    <manufacturerSrn>IN-MF-000017539</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>M040503</emdnCode>
    <emdnDescription>GELATINE SPONGE HAEMOSTATIC DRESSINGS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SCFS 1042</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T05:08:55.144Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904085031404</udiDi>
    <basicUdiDi>B-08904085031404</basicUdiDi>
    <tradeName>Scrofalon</tradeName>
    <deviceName>Scrofalon</deviceName>
    <manufacturerName>EUCARE PHARMACEUTICALS PRIVATE LIMITED</manufacturerName>
    <manufacturerSrn>IN-MF-000017539</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>M040503</emdnCode>
    <emdnDescription>GELATINE SPONGE HAEMOSTATIC DRESSINGS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SCFS 1041</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T05:08:53.788Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904085031206</udiDi>
    <basicUdiDi>B-08904085031206</basicUdiDi>
    <tradeName>Scrofalon</tradeName>
    <deviceName>Scrofalon</deviceName>
    <manufacturerName>EUCARE PHARMACEUTICALS PRIVATE LIMITED</manufacturerName>
    <manufacturerSrn>IN-MF-000017539</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>M040503</emdnCode>
    <emdnDescription>GELATINE SPONGE HAEMOSTATIC DRESSINGS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SCFS 1021</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T05:08:52.589Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904085031176</udiDi>
    <basicUdiDi>B-08904085031176</basicUdiDi>
    <tradeName>Scrofalon</tradeName>
    <deviceName>Scrofalon</deviceName>
    <manufacturerName>EUCARE PHARMACEUTICALS PRIVATE LIMITED</manufacturerName>
    <manufacturerSrn>IN-MF-000017539</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>M040503</emdnCode>
    <emdnDescription>GELATINE SPONGE HAEMOSTATIC DRESSINGS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SCFS 1018</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T05:08:46.577Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904085031169</udiDi>
    <basicUdiDi>B-08904085031169</basicUdiDi>
    <tradeName>Scrofalon</tradeName>
    <deviceName>Scrofalon</deviceName>
    <manufacturerName>EUCARE PHARMACEUTICALS PRIVATE LIMITED</manufacturerName>
    <manufacturerSrn>IN-MF-000017539</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>M040503</emdnCode>
    <emdnDescription>GELATINE SPONGE HAEMOSTATIC DRESSINGS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SCFS 1017</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T05:08:45.393Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904085031138</udiDi>
    <basicUdiDi>B-08904085031138</basicUdiDi>
    <tradeName>Scrofalon</tradeName>
    <deviceName>Scrofalon</deviceName>
    <manufacturerName>EUCARE PHARMACEUTICALS PRIVATE LIMITED</manufacturerName>
    <manufacturerSrn>IN-MF-000017539</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>M040503</emdnCode>
    <emdnDescription>GELATINE SPONGE HAEMOSTATIC DRESSINGS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SCFS 1014</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T05:08:44.185Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904085031121</udiDi>
    <basicUdiDi>B-08904085031121</basicUdiDi>
    <tradeName>Scrofalon</tradeName>
    <deviceName>Scrofalon</deviceName>
    <manufacturerName>EUCARE PHARMACEUTICALS PRIVATE LIMITED</manufacturerName>
    <manufacturerSrn>IN-MF-000017539</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>M040503</emdnCode>
    <emdnDescription>GELATINE SPONGE HAEMOSTATIC DRESSINGS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SCFS 1013</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T05:08:43.087Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904085031091</udiDi>
    <basicUdiDi>B-08904085031091</basicUdiDi>
    <tradeName>Scrofalon</tradeName>
    <deviceName>Scrofalon</deviceName>
    <manufacturerName>EUCARE PHARMACEUTICALS PRIVATE LIMITED</manufacturerName>
    <manufacturerSrn>IN-MF-000017539</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>M040503</emdnCode>
    <emdnDescription>GELATINE SPONGE HAEMOSTATIC DRESSINGS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SCFS 1010</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T05:08:35.782Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904085031077</udiDi>
    <basicUdiDi>B-08904085031077</basicUdiDi>
    <tradeName>Scrofalon</tradeName>
    <deviceName>Scrofalon</deviceName>
    <manufacturerName>EUCARE PHARMACEUTICALS PRIVATE LIMITED</manufacturerName>
    <manufacturerSrn>IN-MF-000017539</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>M040503</emdnCode>
    <emdnDescription>GELATINE SPONGE HAEMOSTATIC DRESSINGS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SCFS 1008</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T05:08:34.584Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904085031015</udiDi>
    <basicUdiDi>B-08904085031015</basicUdiDi>
    <tradeName>Scrofalon</tradeName>
    <deviceName>Scrofalon</deviceName>
    <manufacturerName>EUCARE PHARMACEUTICALS PRIVATE LIMITED</manufacturerName>
    <manufacturerSrn>IN-MF-000017539</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>M040503</emdnCode>
    <emdnDescription>GELATINE SPONGE HAEMOSTATIC DRESSINGS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SCFS 1002</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T05:08:33.387Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904085031008</udiDi>
    <basicUdiDi>B-08904085031008</basicUdiDi>
    <tradeName>Scrofalon</tradeName>
    <deviceName>Scrofalon</deviceName>
    <manufacturerName>EUCARE PHARMACEUTICALS PRIVATE LIMITED</manufacturerName>
    <manufacturerSrn>IN-MF-000017539</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>M040503</emdnCode>
    <emdnDescription>GELATINE SPONGE HAEMOSTATIC DRESSINGS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SCFS 1001</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T05:08:32.213Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904085000493</udiDi>
    <basicUdiDi>B-08904085000493</basicUdiDi>
    <tradeName>Gelspon-P</tradeName>
    <deviceName>Gelspon-P</deviceName>
    <manufacturerName>EUCARE PHARMACEUTICALS PRIVATE LIMITED</manufacturerName>
    <manufacturerSrn>IN-MF-000017539</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>M040503</emdnCode>
    <emdnDescription>GELATINE SPONGE HAEMOSTATIC DRESSINGS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GSPS 1050</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T05:08:26.298Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904085000479</udiDi>
    <basicUdiDi>B-08904085000479</basicUdiDi>
    <tradeName>Gelspon-P</tradeName>
    <deviceName>Gelspon-P</deviceName>
    <manufacturerName>EUCARE PHARMACEUTICALS PRIVATE LIMITED</manufacturerName>
    <manufacturerSrn>IN-MF-000017539</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>M040503</emdnCode>
    <emdnDescription>GELATINE SPONGE HAEMOSTATIC DRESSINGS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GSPS 1048</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T05:08:23.765Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904085000462</udiDi>
    <basicUdiDi>B-08904085000462</basicUdiDi>
    <tradeName>Gelspon-P</tradeName>
    <deviceName>Gelspon-P</deviceName>
    <manufacturerName>EUCARE PHARMACEUTICALS PRIVATE LIMITED</manufacturerName>
    <manufacturerSrn>IN-MF-000017539</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>M040503</emdnCode>
    <emdnDescription>GELATINE SPONGE HAEMOSTATIC DRESSINGS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GSPS 1047</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T05:08:22.569Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904085000455</udiDi>
    <basicUdiDi>B-08904085000455</basicUdiDi>
    <tradeName>Gelspon-P</tradeName>
    <deviceName>Gelspon-P</deviceName>
    <manufacturerName>EUCARE PHARMACEUTICALS PRIVATE LIMITED</manufacturerName>
    <manufacturerSrn>IN-MF-000017539</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>M040503</emdnCode>
    <emdnDescription>GELATINE SPONGE HAEMOSTATIC DRESSINGS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GSPS 1046</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T05:08:21.376Z</lastUpdated>
  </row>
</eudamedExport>